Abstract

Regulatory B cells (Breg) are considered as immunosuppressive cells. Different subsets of Breg cells have been identified both in human beings and in mice. However, there is a lack of unique markers to identify Breg cells, and the heterogeneity of Breg cells in different organs needs to be further illuminated. In this study, we performed high-throughput single-cell RNA sequencing (scRNA-seq) and single-cell B-cell receptor sequencing (scBCR-seq) of B cells from the murine spleen, liver, mesenteric lymph nodes, bone marrow, and peritoneal cavity to better define the phenotype of these cells. Breg cells were identified based on the expression of immunosuppressive genes and IL-10-producing B (B10) cell-related genes, to define B10 and non-B10 subsets in Breg cells based on the score of the B10 gene signatures. Moreover, we characterized 19 common genes significantly expressed in Breg cells, including Fcrl5, Zbtb20, Ccdc28b, Cd9, and Ptpn22, and further analyzed the transcription factor activity in defined Breg cells. Last, a BCR analysis was used to determine the clonally expanded clusters and the relationship of Breg cells across different organs. We demonstrated that Atf3 may potentially modulate the function of Breg cells as a transcription factor and that seven organ-specific subsets of Breg cells are found. Depending on gene expression and functional modules, non-B10 Breg cells exhibited activated the TGF-β pathway, thus suggesting that non-B10 Breg cells have specific immunosuppressive properties different from conventional B10 cells. In conclusion, our work provides new insights into Breg cells and illustrates their transcriptional profiles and BCR repertoire in different organs under physiological conditions.

Highlights

  • Regulatory B (Breg) cells have been reported as a special subset of human and murine CD19+ B cells [1], capable of negatively regulating the immune response in mouse models of autoimmune diseases [2], allergy [3], and infections [4], depending on interleukin 10 (IL-10)

  • We delineated the distribution of Breg cells in the t-distributed stochastic neighbor embedding (t-SNE) plot of total B cells from the liver, spleen, Bone marrow (BM), peritoneal cavity (PC), and mesenteric lymph nodes (mLN) (Figure 1D), and there was a significantly higher proportion of Breg cells in the PC compared with other organs (Figure 1E)

  • We investigated the potential biological function of different Breg cell clusters of all organs using gene set variation analysis (GSVA) and our analysis indicated that the gene profiles displayed biological process enrichment in negative regulation of interleukin 12 (IL-12) and interferon g (IFN-g) production in the Breg1 subset, while the Breg2 subset possessed genes enriched in negative regulation of interleukin 6 (IL-6) and interleukin 4 (IL-4) production while promoting the production of transforming growth factor-b (TGF-b)

Read more

Summary

Introduction

Regulatory B (Breg) cells have been reported as a special subset of human and murine CD19+ B cells [1], capable of negatively regulating the immune response in mouse models of autoimmune diseases [2], allergy [3], and infections [4], depending on IL-10. Breg cells have been identified in various organs of mice like the spleen, draining lymph nodes, and peritoneal cavity [11,12,13,14]. Their phenotypes and functions are still obscure and the heterogeneity of Breg cells in different organs warrants further characterization. The single-cell RNA sequencing (scRNA-seq) technology provides a unique strategy to understand Breg cell complexity and heterogeneity by identifying cell subsets and functional pathways [15]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call